NCT04496778

Brief Summary

Alzheimer's is a type of dementia that affects memory, thinking and behavior. Symptoms eventually grow severe enough to interfere with daily tasks. this study aimed to delay the deterioration of anemic elderly condition as memory affection interfere with daily life activities and social interaction

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable alzheimer-disease

Timeline
Completed

Started Jan 2020

Shorter than P25 for not_applicable alzheimer-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 3, 2020

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 27, 2020

Completed
1 day until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 28, 2020

Completed
4 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 3, 2020

Completed
Last Updated

August 25, 2020

Status Verified

August 1, 2020

Enrollment Period

7 months

First QC Date

July 27, 2020

Last Update Submit

August 23, 2020

Conditions

Keywords

low level laserquality of life

Outcome Measures

Primary Outcomes (4)

  • change of cognitive function

    comparison of Montreal assessment scale scores before and after the intervention It range between 0 and 30. A score of 26 or over is considered to be normal.

    3 months

  • changes of hemoglobin level

    comparison of hemoglobin level for those anemic elderly before and after the intervention

    3 months

  • changes of balance

    comparison of berg balance scale scores before and after the intervention. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function

    3 months

  • changes of quality of life

    comparison of quality of life for Alzheimer disease scores before and after the intervention. It comprised of 13 items (physical health, energy, mood, living situation, memory, family, marriage, friends, self as a whole, ability to do chores, ability to do things for fun, money and life as a whole) for a total score of 13-52 with higher scores indicating better quality of life

    3 months

Secondary Outcomes (2)

  • changes of body mass index

    3 months

  • changes of waist hip ratio

    3 months

Study Arms (2)

low level laser plus exercise

ACTIVE COMPARATOR

acupuncture low level laser combined with nasal laser irradiation in addition to aerobic exercise 3 times per week for 3 months

Device: low level laser therapy ( laser acupuncture combined with nasal laser irradiation)Other: aerobic exercise

sham laser plus exercise

PLACEBO COMPARATOR

placebo acupuncture low level laser combined with nasal laser irradiation in addition to aerobic exercise 3 times per week for 3 months

Device: low level laser therapy ( laser acupuncture combined with nasal laser irradiation)Other: aerobic exercise

Interventions

Cold Laser Therapy Watch (Laser Watch- 650 nm) combines acupuncture and nasal cavity for external blood irradiation. Laser watch with 10 laser beams - is applied to the left wrist. Nasal Probe with 2 laser beams - is applied to the nose cavity

low level laser plus exercisesham laser plus exercise

3 d/week for 45 to 60 minutes per session for 3 months. started by 40%-50% Heart Rate Reserve (determined by using a walking treadmill exercise test) during the first 6 weeks increasing gradually up to 50%-70% Heart Rate Reserve

low level laser plus exercisesham laser plus exercise

Eligibility Criteria

Age65 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Sixty elderly patients aged from 65-75 y
  • Body mass index (BMI) ranged from 30 to 34.9 kg/m2
  • Mild cognitive dysfunction (Montreal cognitive assessment scores from 19-25
  • Anemic
  • The time between their diagnoses and participation in the study ranged from 6 months to 2 years

You may not qualify if:

  • Moderate to severe cognitive impairment
  • History of neurological disease ,stroke or Cardiovascular disease
  • History of nasal bleeding or fracture
  • Known photo-sensitivity disorder
  • Current active cancer or within one year of cancer treatment or remission
  • Serious mental health illness that in the opinion of the investigator would preclude the subject from study participation
  • Active infection, wound or other external trauma to the target area to receive the laser therapy
  • Participation in a clinical study or other type of research in the past 30 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo

Giza, Dokki, 11432, Egypt

Location

Related Publications (1)

  • Nagy EN, Ali AY, Behiry ME, Naguib MM, Elsayed MM. Impact of Combined Photo-Biomodulation and Aerobic Exercise on Cognitive Function and Quality-of-Life in Elderly Alzheimer Patients with Anemia: A Randomized Clinical Trial. Int J Gen Med. 2021 Jan 14;14:141-152. doi: 10.2147/IJGM.S280559. eCollection 2021.

MeSH Terms

Conditions

Alzheimer DiseaseCognitive Dysfunction

Interventions

Low-Level Light TherapyExercise

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersCognition Disorders

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapyMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Ebtesam Nabil, doctoral

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

July 27, 2020

First Posted

August 3, 2020

Study Start

January 3, 2020

Primary Completion

July 28, 2020

Study Completion

August 1, 2020

Last Updated

August 25, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL
Time Frame
after 2 years of study completion till 3 months after
Access Criteria
students and scientific researchers will be allowed to access
More information

Locations